"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
Descriptor ID |
D018426
|
MeSH Number(s) |
E05.318.308.970.725 N04.452.859.819.725 N05.715.360.300.715.700.725 N06.850.520.308.970.725
|
Concept/Terms |
SEER Program- SEER Program
- Program, SEER
- SEER Program (National Cancer Institute (U.S.))
- Surveillance, Epidemiology, and End Results Program
|
Below are MeSH descriptors whose meaning is more general than "SEER Program".
Below are MeSH descriptors whose meaning is more specific than "SEER Program".
This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 3 | 0 | 3 |
1996 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 2 | 2 |
2000 | 1 | 0 | 1 |
2001 | 1 | 2 | 3 |
2002 | 0 | 3 | 3 |
2003 | 1 | 5 | 6 |
2004 | 1 | 7 | 8 |
2005 | 1 | 12 | 13 |
2006 | 2 | 16 | 18 |
2007 | 3 | 16 | 19 |
2008 | 1 | 23 | 24 |
2009 | 1 | 20 | 21 |
2010 | 2 | 21 | 23 |
2011 | 3 | 23 | 26 |
2012 | 4 | 25 | 29 |
2013 | 2 | 36 | 38 |
2014 | 7 | 37 | 44 |
2015 | 1 | 29 | 30 |
2016 | 3 | 24 | 27 |
2017 | 1 | 23 | 24 |
2018 | 5 | 30 | 35 |
2019 | 7 | 28 | 35 |
2020 | 0 | 14 | 14 |
2021 | 1 | 18 | 19 |
2022 | 0 | 6 | 6 |
2023 | 1 | 4 | 5 |
2024 | 15 | 11 | 26 |
To return to the timeline,
click here.
Below are the most recent publications written about "SEER Program" by people in Profiles.
-
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. ESMO Open. 2024 Nov; 9(11):103934.
-
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare. Int J Gynecol Cancer. 2024 Nov 04; 34(11):1661-1670.
-
Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework. J Natl Cancer Inst. 2024 Nov 01; 116(11):1798-1806.
-
Pediatric sporadic Burkitt lymphoma of the head and neck: A case series and analysis of national trends. Int J Pediatr Otorhinolaryngol. 2024 Nov; 186:112137.
-
Pediatric Ewing Sarcoma Presentation, Treatment, and Outcomes Across Sociodemographic Groups. J Surg Res. 2024 Nov; 303:322-331.
-
Secondary databases in gynecologic cancer research. Int J Gynecol Cancer. 2024 Oct 07; 34(10):1619-1629.
-
Regional Variation in Deescalated Therapy in Older Adults With Early-Stage Breast Cancer. JAMA Netw Open. 2024 Oct 01; 7(10):e2441152.
-
Epidemiology of dermatofibrosarcoma protuberans among Asian-American sub-groups: a population-based study of the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol Res. 2024 Sep 26; 316(9):637.
-
Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 11; 15(8):102071.
-
The prognostic impact of tumor deposits in colorectal cancer: More than just N1c. Cancer. 2024 Dec 01; 130(23):4052-4060.